HOME > BUSINESS > Article

Text Size

small

medium

large


Shionogi to Acquire Torii Pharmaceutical

Shionogi to Acquire Torii Pharmaceutical

Isao Teshirogi (center), president and CEO of Shionogi, shakes hands with Nobumasa Kondo (right), president and CEO of Torii Pharmaceutical, and Koji Shimayoshi, executive vice president at Japan Tobacco, in Tokyo on Wednesday.
Isao Teshirogi (center), president and CEO of Shionogi, shakes hands with Nobumasa Kondo (right), president and CEO of Torii Pharmaceutical, and Koji Shimayoshi, executive vice president at Japan Tobacco, in Tokyo on Wednesday.

   Tokyo, May 7 (Jiji Press)--Japanese drugmaker Shionogi & Co. said Wednesday that it will acquire Torii Pharmaceutical Co., a unit of Japan Tobacco Inc., for about 160 billion yen.
   Shionogi will aim to make Torii a fully owned subsidiary by conducting a tender offer and buying JT's stake in the firm. JT will fully withdraw from the pharmaceutical business, transferring all related operations other than Torii to Shionogi as well.

To read a full story, please click here to find out how to subscribe.

HEADLINES

POLITICS
Japan Aims to Develop Ties with Vatican under New Pope Leo XIV: Govt Spokesman
ECONOMY
Nissan Abandons Plan to Build EV Battery Plant in Fukuoka, Southwestern Japan
SPORTS
MLB: Ohtani Hits 11th Home Run of Season in Dodgers' 5-3 Loss to Diamondbacks
OTHER
Gates Foundation to Donate $200 B. over Next 20 Years, Close Doors by 2045

AFP-JIJI PRESS NEWS JOURNAL


Photos